FDA Blames Over-Reporting For Record-High Recall Count In 2013
This article was originally published in The Gray Sheet
The number of medical device recalls initiated by manufacturers last year hit an all-time high, likely caused in part by over-reporting of recalls by wary firms that were dinged in the past by FDA for not reporting. “Once a firm has been cited by an investigator, it is a wonderful reporter of recalls after that,” an agency official says.
You may also be interested in...
FDA is investigating hundreds of cases of radiation overexposure from computed tomography (CT) imaging scans to determine whether the overdoses were caused by human error or a problem with the devices
The US agency says in the latest update to its medical device shortages guidance doc that it’ll send enforcement missives to companies that don’t notify the agency of a “permanent discontinuance or an interruption in manufacturing” of products deemed critical during the COVID-19 pandemic.
In the only device-related warning letter released by the US FDA this week, Avazo Healthcare was selling two COVID-19 antigen tests without approval, clearance or authorization from the agency.